دورية أكاديمية

Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries

التفاصيل البيبلوغرافية
العنوان: Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
المؤلفون: Cerebral Venous Sinus Thrombosis with Thrombocytopenia Syndrome Study Group, van de Munckhof, Anita, Borhani-Haghighi, Afshin, Aaron, Sanjith, Krzywicka, Katarzyna, van Kammen, Mayte Sanchez, Cordonnier, Charlotte, Kleinig, Timothy J., Field, Thalia S., Poli, Sven, Lemmens, Robin, Scutelnic, Adrian, Lindgren, Erik, Duan, Jiangang, Arslan, Yildiz, van Gorp, Eric C. M., Kremer Hovinga, Johanna A., Guenther, Albrecht, Jood, Katarina, Tatlisumak, Turgut, Putaala, Jukka, Heldner, Mirjam R., Arnold, Marcel, de Sousa, Diana Aguiar, Wasay, Mohammad, Arauz, Antonio, Conforto, Adriana Bastos, Ferro, Jose M., Coutinho, Jonathan M.
المساهمون: HUS Neurocenter, Clinicum, Department of Neurosciences, Neurologian yksikkö
بيانات النشر: Wiley/Blackwell
سنة النشر: 2023
المجموعة: Helsingfors Universitet: HELDA – Helsingin yliopiston digitaalinen arkisto
مصطلحات موضوعية: Covid-19, Cvst, Vitt, Global health, Thrombosis, Vaccination, 3124 Neurology and psychiatry
الوصف: Background: Adenovirus-based COVID-19 vaccines are extensively used in low- and middle-income countries (LMICs). Remarkably, cases of cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) have rarely been reported from LMICs. Aims: We studied the frequency, manifestations, treatment, and outcomes of CVST-VITT in LMICs. Methods: We report data from an international registry on CVST after COVID-19 vaccination. VITT was classified according to the Pavord criteria. We compared CVST-VITT cases from LMICs to cases from high-income countries (HICs). Results: Until August 2022, 228 CVST cases were reported, of which 63 were from LMICs (all middle-income countries [MICs]: Brazil, China, India, Iran, Mexico, Pakistan, Turkey). Of these 63, 32 (51%) met the VITT criteria, compared to 103 of 165 (62%) from HICs. Only 5 of the 32 (16%) CVST-VITT cases from MICs had definite VITT, mostly because anti-platelet factor 4 antibodies were often not tested. The median age was 26 (interquartile range [IQR] 20-37) versus 47 (IQR 32-58) years, and the proportion of women was 25 of 32 (78%) versus 77 of 103 (75%) in MICs versus HICs, respectively. Patients from MICs were diagnosed later than patients from HICs (1/32 [3%] vs. 65/103 [63%] diagnosed before May 2021). Clinical manifestations, including intracranial hemorrhage, were largely similar as was intravenous immunoglobulin use. In-hospital mortality was lower in MICs (7/31 [23%, 95% confidence interval (CI) 11-40]) than in HICs (44/102 [43%, 95% CI 34-53], p = 0.039). Conclusions: The number of CVST-VITT cases reported from LMICs was small despite the widespread use of adenoviral vaccines. Clinical manifestations and treatment of CVST-VITT cases were largely similar in MICs and HICs, while mortality was lower in patients from MICs. ; Peer reviewed
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article:& nbsp;Netherlands Organization for Health Research and Development (ZonMw, grant 10430072110005), Dr CJ Vaillant Foundation, Hospital District of Helsinki and Uusimaa (grant TYH2022223); Cerebral Venous Sinus Thrombosis with Thrombocytopenia Syndrome Study Group , van de Munckhof , A , Borhani-Haghighi , A , Aaron , S , Krzywicka , K , van Kammen , M S , Cordonnier , C , Kleinig , T J , Field , T S , Poli , S , Lemmens , R , Scutelnic , A , Lindgren , E , Duan , J , Arslan , Y , van Gorp , E C M , Kremer Hovinga , J A , Guenther , A , Jood , K , Tatlisumak , T , Putaala , J , Heldner , M R , Arnold , M , de Sousa , D A , Wasay , M , Arauz , A , Conforto , A B , Ferro , J M & Coutinho , J M 2023 , ' Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries ' , International Journal of Stroke , vol. 18 , no. 9 , pp. 1112-1120 . https://doi.org/10.1177/17474930231182901Test; b75f3683-8102-45a8-8e27-741d9e5df4fc; http://hdl.handle.net/10138/567787Test; 001019131700001
الإتاحة: http://hdl.handle.net/10138/567787Test
حقوق: cc_by ; openAccess ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.7B40F829
قاعدة البيانات: BASE